GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » Cash And Cash Equivalents

OKAIF (EvokAI Creative Labs) Cash And Cash Equivalents : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is EvokAI Creative Labs Cash And Cash Equivalents?

EvokAI Creative Labs's quarterly cash and cash equivalents declined from Mar. 2024 ($0.32 Mil) to Jun. 2024 ($0.06 Mil) but then stayed the same from Jun. 2024 ($0.06 Mil) to Sep. 2024 ($0.00 Mil).

EvokAI Creative Labs's annual cash and cash equivalents declined from Dec. 2021 ($0.01 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.77 Mil).

EvokAI Creative Labs Cash And Cash Equivalents Historical Data

The historical data trend for EvokAI Creative Labs's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EvokAI Creative Labs Cash And Cash Equivalents Chart

EvokAI Creative Labs Annual Data
Trend Dec21 Dec22 Dec23
Cash And Cash Equivalents
0.01 - 0.77

EvokAI Creative Labs Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.77 0.32 0.06 -

EvokAI Creative Labs Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

EvokAI Creative Labs  (OTCPK:OKAIF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

EvokAI Creative Labs Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

EvokAI Creative Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » Cash And Cash Equivalents
Comparable Companies
TSX:VHI TSXV:XYBN TSXV:DOC TSXV:ADK XCNQ:HS XCNQ:AIAI TSXV:THNK TSXV:NEWU TSXV:NURS TSXV:CDX GEHC VEEV TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY TDOC
Traded in Other Exchanges
OKAI:Canada
Address
609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
Website
https://www.evokailabs.com
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.